Healthcare
India's HealthifyMe gets $6m Series A round
IDG Ventures, Inventus Capital and Blume Ventures have led a $6 million Series A round for Indian health and fitness app developer HealthifyMe.
Deal focus: VCs back ACT’s customized cancer care model
Taiwan-based ACT Genomics will use its Series B funding to expand its genetic sequencing and molecular testing services - typically used by doctors in cancer treatment - to other Asian markets
Warburg Pincus backs Chinese private hospital chain UIB
Warburg Pincus has invested an undisclosed sum in UIB, a Shanghai-based hospital chain that focuses on obstetrics, gynecology and pediatrics.
Taiwan's ACT Genomics gets $12.5m Series B round
Hotung Group and CDIB Capital has led a $12.5 million Series B round of funding for ACT Genomics, a Taiwan-based company that provides information to cancer treatment specialists.
Sino-US biopharma player gets $10m round
Sino-US biopharmaceutical company Sirnaomics has raised $10 million in a Series B round led by Hong Kong-based venture capital firm Value Measured Investment.
IFC leads $60m round for India's Lenskart
The International Finance Corporation (IFC) has led a INR4 billion ($60 million) Series D round of funding for Indian online eyewear retailer Lenskart.
TPG buys India-focused CTSI for $33m
TPG Capital has bought a majority stake in Cancer Treatment Services International (CTSI), a US cancer treatment chain focused on India and South Asia. AVCJ understands that the firm paid $33 million for a 65% interest.
Deal focus: Hua Medicine gets cross-border injection
Following its $50 million Series C round, investors in Hua Medicine are waiting for the company to fulfill its potential as a poster child of innovation in China
Harvest leads $50m round for China’s Hua Medicine
Harvest Fund Management has led a $50 million Series C round – which was more than 3x oversubscribed – for China-based clinical-stage diabetes treatment developer Hua Medicine.
China’s Qiming to launch US healthcare fund
China-focused GP Qiming Venture Partners is planning to raise a healthcare-dedicated fund in the US that will help China- and US-based start-ups expand in both markets.
Maverick leads $15m Series B for India's 1mg
Maverick Capital Ventures, the VC affiliate of hedge fund Maverick Capital, has led a INR1 billion ($15 million) Series B round for Indian online pharmaceutical platform 1mg.
Ally Bridge leads $150m round for US cancer treatment firm
San Diego-based cancer treatment developer Sorrento Therapeutics has raised about $150 million from a group of investors led by China-focused healthcare specialist Ally Bridge Group.
Samara buys Adcock Ingram India for $23m
Samara Capital has paid INR1.51 billion ($22.7 million) for the Indian division of South African drug maker Adcock Ingram Holdings.
Ally Bridge backs Chinese oncology-focused big data company
Healthcare-focused GP Ally Bridge Group has led a Series B round of funding for LinkDoc Technology, an oncology-focused big data company based in China.
Healthcare specialist TVM boosts Southeast Asia coverage
TVM Capital Healthcare Partners, which focuses on healthcare investments in emerging markets, has deepened its coverage of Southeast Asia with the appointment of one operating partner and two senior advisors in Singapore.
CITIC PE invests in China's New Journey Hospital
CITIC Private Equity (CITIC PE) has invested an undisclosed sum in New Journey Hospital Group, a Chinese cancer hospital operator.
Carlyle-backed Zhongmei Healthcare files for HK IPO
Carlyle Group-backed hospital operator Zhongmei Healthcare has filed for a Hong Kong IPO.
Goldman invests $37m in China's Venus Medtech
Goldman Sachs has committed $37 million to cardiac valve developer Venus Medtech.
Affinity buys Australia's Medical Director for $117 million
Affinity Equity Partners has bought Australia-based clinic management software developer Medical Director for A$155 million ($117 million).
J-Star completes buyout of Japan's Aisei Pharmacy
J-Star has completed its takeover of Japanese drugstore chain Aisei Pharmacy in a deal valued at JPY11.4 billion ($101 million).
Thailand’s Medical Departures raises $2.5m
Singapore-based venture capital firm DMP has led a $2.5 million Series A round for clinical services marketplace Medical Departures.
China hospitals: Long-term cure?
Hospitals have emerged as a phenomenally popular target for private equity in China, but it may take time for ambitious growth projections to be realized
Fosun Kinzon leads $15m round for China medical app
Fosun Kinzon Capital, a VC arm backed by Fosun Group, has led a RMB100 million ($15 million) Series B round for Easyhin, a Chinese mobile app that provides healthcare services to mothers and children.
Bain buys China hospital operator
Bain Capital has acquired a majority stake in China-based hospital operator Asia Pacific Medical Group (APMG) for $150 million. With many investors pursuing hospital roll-up strategies – and pushing up M&A valuations – it will focus on expanding the...